Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion type Assertion NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_head.
- NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion description "[The following variables were associated with recurrent PSC in our cohort: presence of human leukocyte antigen (HLA)-DRB1*08 (29% versus 2%; P= 0.026; odds ratio [OR], 24.4; 95% confidence interval [CI], 1.8-318.1), acute cellular rejection (ACR) (71% versus 22%; P= 0.015; OR, 8.7; 95% CI, 1.5-49.9), and steroid-resistant ACR (29% versus 0%; P= 0.012).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_provenance.
- NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion evidence source_evidence_literature NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_provenance.
- NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion SIO_000772 18236405 NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_provenance.
- NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion wasDerivedFrom befree-20140225 NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_provenance.
- NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_assertion wasGeneratedBy ECO_0000203 NP526981.RAGuc728DVG56WIX2kIrasMEoCD9Wn3FbuFbP6BABCiAg130_provenance.